Wednesday, September 05, 2012 12:24:47 AM
http://www.chinadaily.com.cn/business/2012-09/04/content_15731328.htm
"Private medical companies are being encouraged to take a more active role in the growing treatment of chronic disease in China, especially as the population continues to increase its wealth.
In fact, the rise in many of the more common conditions is actually being attributed to the adoption of lifestyles often associated with more affluent populations, according to Wu Yangfeng, a professor with the School of Public Health at Peking University."
Just some more general news/info on private end of medical field MDCE may be entering in China.
MDCE
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
